* Amicus unlikely to file application this year * Had earlier expected to file application by Q4 * Drug aims to be first oral drug for Fabry disease * Company says European filing on track * Stock slumps as much as 59 pct (Adds details)   By Natalie Grover Oct 2 (Reuters) – Amicus Therapeutics […]

AstraZeneca Plc on Thursday said the U.S. Food and Drug Administration approved a new dose of its blood thinner Brilinta intended for longer-term use in patients with a history of heart attack or a condition known as acute coronary syndrome. The FDA approved Brilinta tablets at a new 60 milligram dose that would be taken […]

A new diabetes pill from Eli Lilly and Co and Boehringer Ingelheim cut risk of heart attack, stroke and death in a closely watched study, the first glucose-lowering drug to show such protective results in a large cardiovascular trial, the drugmakers said on Thursday. Besides burnishing the image of the year-old drug, Jardiance, the results […]

Bellerophon Therapeutics Inc said its implantable heart device failed to prevent heart failure in patients in a large study, casting doubts over an approval for the device in Europe. The device, Bioabsorbable Cardiac Matrix (BCM), was licensed to Bellerophon by BioLineRx Ltd in 2009. BioLineRx’s U.S.-listed shares fell 18 percent to $1.76 in premarket trading […]

MAASTRICHT, Netherlands, July 20, 2015 /PRNewswire/ — Between 1-2% of the population complains of chest pain every year. In emergency medicine, typically 60% of those patients will be diagnosed as potentially at risk of heart disease and most will be admitted to hospital for observation under the current guidelines for health care systems such as […]

EUGENE, Ore., July 10, 2015 /PRNewswire/ — The U.S. Food and Drug Administration announced that it is strengthening an existing label warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of heart attack or stroke. The new policy pertains to both over-the-counter and prescription NSAID labels. The FDA reached its decision to strengthen NSAID warning […]

The U.S. food and Drug Administration said it was strengthening an existing warning label that non-aspirin, non-steroidal anti-inflammatory drugs (NSAIDs) increase the chance of a heart attack or stroke. NSAIDs are used to treat pain and fever from medical conditions such as arthritis, menstrual cramps, headaches, colds, and the flu, and some of the better-known […]

Based on results of a new study from researchers at Houston Methodist and Stanford University, adults who take proton pump inhibitors (PPIs) for heartburn and other gastrointestinal ailments are between 16 and 21 percent more likely to experience a heart attack than those who do not use the widely available acid blocker. The study was […]